Reported Earnings • May 05
First quarter 2026 earnings released First quarter 2026 results: Revenue: ₫2.22t (down 42% from 1Q 2025). Net income: ₫153.7b (up 240% from 1Q 2025). Profit margin: 6.9% (up from 1.2% in 1Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Vietnam. Tillkännagivande • Apr 04
An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 07, 2026 An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 07, 2026, at 09:00 SE Asia Standard Time. Location: head ofice - lot cni1+cn12, an dong industrial-, cluster, nam sach commune, hai phong city Vietnam Reported Earnings • Jan 29
Full year 2025 earnings released: EPS: ₫947 (vs ₫964 in FY 2024) Full year 2025 results: EPS: ₫947. Revenue: ₫11t (down 16% from FY 2024). Net income: ₫372.9b (up 1.2% from FY 2024). Profit margin: 3.5% (up from 2.9% in FY 2024). The increase in margin was driven by lower expenses. Reported Earnings • Nov 01
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: ₫2.37t (down 26% from 3Q 2024). Net income: ₫117.6b (up 439% from 3Q 2024). Profit margin: 5.0% (up from 0.7% in 3Q 2024). The increase in margin was driven by lower expenses. New Risk • Jul 31
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.0% Last year net profit margin: 4.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.0% net profit margin). Reported Earnings • Jul 31
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: ₫2.31t (down 17% from 2Q 2024). Net income: ₫121.3b (down 11% from 2Q 2024). Profit margin: 5.3% (up from 4.9% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. New Risk • Jun 01
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 4.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company. Upcoming Dividend • May 23
Upcoming dividend of ₫300 per share Eligible shareholders must have bought the stock before 30 May 2025. Payment date: 20 June 2025. The company last paid an ordinary dividend in June 2014. The average dividend yield among industry peers is 3.8%. New Risk • May 01
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.0% Last year net profit margin: 3.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company. New Risk • Apr 09
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₫2.45t (US$93.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Apr 09
Investor sentiment deteriorates as stock falls 25% After last week's 25% share price decline to ₫6,410, the stock trades at a trailing P/E ratio of 6.6x. Average trailing P/E is 11x in the Chemicals industry in Vietnam. Total loss to shareholders of 63% over the past three years. Tillkännagivande • Apr 09
An Phat Bioplastics Joint Stock Company, Annual General Meeting, Apr 28, 2025 An Phat Bioplastics Joint Stock Company, Annual General Meeting, Apr 28, 2025, at 09:00 SE Asia Standard Time. Location: lot cn11-, cn12 an dong industrial park, nam sach town, nam sach district, hai duong province., Vietnam Reported Earnings • Apr 08
Full year 2024 earnings released: EPS: ₫964 (vs ₫651 in FY 2023) Full year 2024 results: EPS: ₫964 (up from ₫651 in FY 2023). Revenue: ₫13t (up 1.3% from FY 2023). Net income: ₫368.6b (up 48% from FY 2023). Profit margin: 2.9% (up from 2.0% in FY 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings. Reported Earnings • Jan 30
Full year 2024 earnings released: EPS: ₫947 (vs ₫757 in FY 2023) Full year 2024 results: EPS: ₫947 (up from ₫757 in FY 2023). Revenue: ₫13t (up 1.3% from FY 2023). Net income: ₫361.8b (up 25% from FY 2023). Profit margin: 2.8% (up from 2.3% in FY 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings. Reported Earnings • Oct 30
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: ₫3.19t (down 9.5% from 3Q 2023). Net income: ₫21.8b (down 78% from 3Q 2023). Profit margin: 0.7% (down from 2.8% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Sep 27
Standing Deputy General Director recently sold ₫2.0b worth of stock On the 20th of September, Thoan Tran sold around 200k shares on-market at roughly ₫10,000 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Tillkännagivande • Sep 12
An Phat Bioplastics Joint Stock Company (HOSE:AAA) agreed to acquire additional 15.3% stake in Hanoi Plastics Joint Stock Company (HOSE:NHH) from An Phat Holdings Joint Stock Company (HOSE:APH). An Phat Bioplastics Joint Stock Company (HOSE:AAA) agreed to acquire additional 15.3% stake in Hanoi Plastics Joint Stock Company (HOSE:NHH) from An Phat Holdings Joint Stock Company (HOSE:APH) on September 10, 2024. An Phat Holdings Joint Stock Company is selling 11,160,308 shares of Hanoi Plastics Joint Stock Company. An Phat Bioplastics Joint Stock Company will hold 45,732,882 shares equivalent to 62.75% stake in Hanoi Plastics Joint Stock Company. The transaction has been approved by the board of An Phat Holdings Joint Stock Company and An Phat Bioplastics Joint Stock Company. Reported Earnings • Aug 02
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: ₫2.78t (flat on 2Q 2023). Net income: ₫119.4b (up 386% from 2Q 2023). Profit margin: 4.3% (up from 0.9% in 2Q 2023). Reported Earnings • May 01
First quarter 2024 earnings released First quarter 2024 results: Revenue: ₫2.96t (down 18% from 1Q 2023). Net income: ₫134.7b (up 88% from 1Q 2023). Profit margin: 4.5% (up from 2.0% in 1Q 2023). The increase in margin was driven by lower expenses. Tillkännagivande • Apr 28
An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 27, 2024 An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 27, 2024, at 02:00 Coordinated Universal Time. Location: Lot CN11-CN12, An Dong Industrial Cluster, Nam Sach town, Nam Sach disitrct Hai Duong Province Vietnam Reported Earnings • Feb 02
Full year 2023 earnings released: EPS: ₫761 (vs ₫433 in FY 2022) Full year 2023 results: EPS: ₫761 (up from ₫433 in FY 2022). Revenue: ₫13t (down 18% from FY 2022). Net income: ₫290.9b (up 91% from FY 2022). Profit margin: 2.3% (up from 1.0% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Reported Earnings • Nov 02
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: ₫3.53t (up 7.6% from 3Q 2022). Net income: ₫99.0b (up 24% from 3Q 2022). Profit margin: 2.8% (up from 2.4% in 3Q 2022). The increase in margin was driven by higher revenue. Reported Earnings • Aug 03
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: ₫2.79t (down 39% from 2Q 2022). Net income: ₫43.0b (down 50% from 2Q 2022). Profit margin: 1.5% (down from 1.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Reported Earnings • Apr 30
First quarter 2023 earnings released First quarter 2023 results: Revenue: ₫3.62t (down 10% from 1Q 2022). Net income: ₫53.9b (down 39% from 1Q 2022). Profit margin: 1.5% (down from 2.2% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Reported Earnings • Feb 01
Full year 2022 earnings released: EPS: ₫407 (vs ₫994 in FY 2021) Full year 2022 results: EPS: ₫407 (down from ₫994 in FY 2021). Revenue: ₫15t (up 16% from FY 2021). Net income: ₫155.7b (down 46% from FY 2021). Profit margin: 1.0% (down from 2.2% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Board Change • Nov 24
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Nghia Phan was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Aug 25
an Phat Bioplastics Joint Stock Company Announces Relocation of Representative Office On August 22, 2022, the Board of Directors of An Phat Bioplastics Joint Stock Company approved the relocation of representative office as follows: Address before change: B9, No.6/106 Hoang Quoc Viet, Nghia Do ward, Cau Giay district, Ha Noi city. Address after change: Floor 16, PV Oil Building, 148 Hoang Quoc Viet, Nghia Tan ward, Cau Giay district, Ha Noi city. Reported Earnings • Aug 03
Second quarter 2022 earnings released: EPS: ₫259 (vs ₫264 in 2Q 2021) Second quarter 2022 results: EPS: ₫259 (down from ₫264 in 2Q 2021). Revenue: ₫4.61t (up 41% from 2Q 2021). Net income: ₫84.6b (down 2.0% from 2Q 2021). Profit margin: 1.8% (down from 2.6% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Jun 27
Investor sentiment improved over the past week After last week's 16% share price gain to ₫11,900, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 11x in the Chemicals industry in Vietnam. Total loss to shareholders of 19% over the past three years. Tillkännagivande • Jun 01
An Phat Bioplastics Joint Stock Company, Annual General Meeting, Jun 20, 2022 An Phat Bioplastics Joint Stock Company, Annual General Meeting, Jun 20, 2022, at 02:00 Coordinated Universal Time. Location: lot CN11-CN12, An Dong Industrial cluster Nam Sach town, Nam Sach district Hai Duong Province Vietnam Reported Earnings • May 02
First quarter 2022 earnings released: EPS: ₫270 (vs ₫308 in 1Q 2021) First quarter 2022 results: EPS: ₫270. Revenue: ₫4.03t (up 76% from 1Q 2021). Net income: ₫88.1b (up 17% from 1Q 2021). Profit margin: 2.2% (down from 3.3% in 1Q 2021). The decrease in margin was driven by higher expenses. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Cuong Dinh was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 20
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₫14,300, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 14x in the Chemicals industry in Vietnam. Negligible returns to shareholders over past three years. Tillkännagivande • Apr 06
An Phat Bioplastics Joint Stock Company announced that it expects to receive VND 470 billion in funding An Phat Bioplastics Joint Stock Company announced that it will issue 470 bonds for gross proceeds of VND 470,000,000,000 on April 4, 2022. Reported Earnings • Feb 02
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: ₫872 (down from ₫1,191 in FY 2020). Revenue: ₫13t (up 77% from FY 2020). Net income: ₫284.5b (up 8.5% from FY 2020). Profit margin: 2.2% (down from 3.5% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.7%. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Dec 27
Investor sentiment improved over the past week After last week's 21% share price gain to ₫21,900, the stock trades at a trailing P/E ratio of 25.4x. Average forward P/E is 12x in the Chemicals industry in Vietnam. Total returns to shareholders of 90% over the past three years. Upcoming Dividend • Aug 25
Upcoming dividend of ₫500 per share Eligible shareholders must have bought the stock before 01 September 2021. Payment date: 28 October 2021. Trailing yield: 5.6%. Lower than top quartile of Vietnamese dividend payers (7.4%). Higher than average of industry peers (2.5%). Reported Earnings • Aug 04
Second quarter 2021 earnings released The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: ₫3.26t (up 80% from 2Q 2020). Net income: ₫83.4b (up 23% from 2Q 2020). Profit margin: 2.6% (down from 3.7% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Tillkännagivande • Jul 15
An Phat Bioplastics Joint Stock Company announced that it expects to receive VND 296.75997 billion in funding An Phat Bioplastics Joint Stock Company announced a private placement of 29,675,997 shares at a price of VDN 10,000 per share for the gross proceeds of VDN 296,759,970,000 on July 13, 2021. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₫17,300, the stock trades at a trailing P/E ratio of 13.8x. Average forward P/E is 16x in the Chemicals industry in Vietnam. Total returns to shareholders of 9.1% over the past three years. Valuation Update With 7 Day Price Move • Jun 18
Investor sentiment improved over the past week After last week's 22% share price gain to ₫19,150, the stock trades at a trailing P/E ratio of 15.2x. Average forward P/E is 16x in the Chemicals industry in Vietnam. Total returns to shareholders of 12% over the past three years. Tillkännagivande • May 06
An Phat Bioplastics Joint Stock Company has completed a Follow-on Equity Offering in the amount of VND 1.0677 trillion. An Phat Bioplastics Joint Stock Company has completed a Follow-on Equity Offering in the amount of VND 1.0677 trillion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 75,000,000
Price\Range: VND 14236 Price Target Changed • Mar 24
Price target increased to ₫16,700 Up from ₫14,600, the current price target is provided by 1 analyst. New target price is 6.4% above last closing price of ₫15,700. Stock is up 56% over the past year. Valuation Update With 7 Day Price Move • Mar 16
Investor sentiment improved over the past week After last week's 16% share price gain to ₫17,000, the stock trades at a trailing P/E ratio of 14.7x, up from the previous P/E ratio of 12.7x. Average P/E is 13x in the Chemicals industry in Vietnam. Total return to shareholders over the past three years was a loss of 6.4%. Is New 90 Day High Low • Mar 11
New 90-day high: ₫16,200 The company is up 25% from its price of ₫12,950 on 11 December 2020. The Vietnamese market is up 15% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 25% over the same period. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₫12,200, the stock is trading at a trailing P/E ratio of 10.6x, down from the previous P/E ratio of 12.7x. This compares to an average P/E of 12x in the Chemicals industry in Vietnam. Total return to shareholders over the past three years is a loss of 34%. Is New 90 Day High Low • Jan 04
New 90-day high: ₫14,550 The company is up 22% from its price of ₫11,952 on 06 October 2020. The Vietnamese market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. Is New 90 Day High Low • Dec 07
New 90-day high: ₫12,950 The company is up 7.0% from its price of ₫12,048 on 08 September 2020. The Vietnamese market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₫7,619 per share. Is New 90 Day High Low • Nov 19
New 90-day high: ₫12,300 The company is up 5.0% from its price of ₫11,667 on 21 August 2020. The Vietnamese market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₫7,796 per share. Tillkännagivande • Oct 06
An Phat Bioplastics Joint Stock Company Appoints Lam Thi Hien as Deputy Chief Executive Officer The Board resolution dated October 03, 2020, the BOD of An Phat Bioplastics Joint Stock Company approved to appoint Mrs. Lam Thi Hien as Deputy Chief Executive Officer of the Company from October 03, 2020. 
